NDC 17478-419
Chlorothiazide Sodium
Chlorothiazide Sodium
Chlorothiazide Sodium is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Akorn, Inc.. The primary component is Chlorothiazide Sodium.
| Product ID | 17478-419_1dab3243-f1dc-467d-b341-72aea14a0cce |
| NDC | 17478-419 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Chlorothiazide Sodium |
| Generic Name | Chlorothiazide Sodium |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2012-08-13 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA011145 |
| Labeler Name | Akorn, Inc. |
| Substance Name | CHLOROTHIAZIDE SODIUM |
| Active Ingredient Strength | 500 mg/1 |
| Pharm Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |